Co-Authors
This is a "connection" page, showing publications co-authored by Ken Herrmann and Ulf Dittmer.
Connection Strength
0.442
-
Peptide Receptor Radionuclide Therapy During the COVID-19 Pandemic: Are There Any Concerns? J Nucl Med. 2020 Aug; 61(8):1094-1095.
Score: 0.222
-
Impact of COVID-19 on Nuclear Medicine in Germany, Austria and Switzerland: An International Survey in April 2020. Nuklearmedizin. 2020 Aug; 59(4):294-299.
Score: 0.220